CASP3 and cancer: This is demonstrated by studies showing that penta-1,2,3,4,6-O-galloyl-β-D-glucose induces a senescence-like growth arrest in human cancer cells by inducing autophagy and inhibits aggressive phenotypes of HepG2 cells by inducing G1 arrest and activating the caspase-3 cascade [21,22].